55 related articles for article (PubMed ID: 28125447)
1. Tumor-Infiltrating Lymphocytes and Their Prognostic Value in Cutaneous Melanoma.
Maibach F; Sadozai H; Seyed Jafari SM; Hunger RE; Schenk M
Front Immunol; 2020; 11():2105. PubMed ID: 33013886
[TBL] [Abstract][Full Text] [Related]
2. OX40+ Regulatory T Cells in Cutaneous Squamous Cell Carcinoma Suppress Effector T-Cell Responses and Associate with Metastatic Potential.
Lai C; August S; Albibas A; Behar R; Cho SY; Polak ME; Theaker J; MacLeod AS; French RR; Glennie MJ; Al-Shamkhani A; Healy E
Clin Cancer Res; 2016 Aug; 22(16):4236-48. PubMed ID: 27034329
[TBL] [Abstract][Full Text] [Related]
3. Optimization of an automated tumor-infiltrating lymphocyte algorithm for improved prognostication in primary melanoma.
Chou M; Illa-Bochaca I; Minxi B; Darvishian F; Johannet P; Moran U; Shapiro RL; Berman RS; Osman I; Jour G; Zhong H
Mod Pathol; 2021 Mar; 34(3):562-571. PubMed ID: 33005020
[TBL] [Abstract][Full Text] [Related]
4. Leukocyte infiltration and tumor cell plasticity are parameters of aggressiveness in primary cutaneous melanoma.
Hillen F; Baeten CI; van de Winkel A; Creytens D; van der Schaft DW; Winnepenninckx V; Griffioen AW
Cancer Immunol Immunother; 2008 Jan; 57(1):97-106. PubMed ID: 17602225
[TBL] [Abstract][Full Text] [Related]
5. Glioma-derived S100A9 polarizes M2 microglia to inhibit CD8+T lymphocytes for immunosuppression via αvβ3 integrin/AKT1/TGFβ1.
Huang N; Tang J; Yi X; Zhang M; Li B; Cheng Y; Chen J
Biochim Biophys Acta Mol Cell Res; 2024 Jan; 1871(1):119619. PubMed ID: 37907196
[TBL] [Abstract][Full Text] [Related]
6. Regulatory T cells in tumor microenvironment: new mechanisms, potential therapeutic strategies and future prospects.
Li C; Jiang P; Wei S; Xu X; Wang J
Mol Cancer; 2020 Jul; 19(1):116. PubMed ID: 32680511
[TBL] [Abstract][Full Text] [Related]
7. Diversity of intratumoral regulatory T cells in B-cell non-Hodgkin lymphoma.
Spasevska I; Sharma A; Steen CB; Josefsson SE; Blaker YN; Kolstad A; Rustad EH; Meyer S; Isaksen K; Chellappa S; Kushekhar K; Beiske K; Førsund MS; Spetalen S; Holte H; Østenstad B; Brodtkorb M; Kimby E; Olweus J; Taskén K; Newman AM; Lorenz S; Smeland EB; Alizadeh AA; Huse K; Myklebust JH
Blood Adv; 2023 Dec; 7(23):7216-7230. PubMed ID: 37695745
[TBL] [Abstract][Full Text] [Related]
8. Extracellular adenosine metabolism in immune cells in melanoma.
Umansky V; Shevchenko I; Bazhin AV; Utikal J
Cancer Immunol Immunother; 2014 Oct; 63(10):1073-80. PubMed ID: 24756420
[TBL] [Abstract][Full Text] [Related]
9. Tozasertib activates anti-tumor immunity through decreasing regulatory T cells in melanoma.
Wang Q; Liu W; Zhou H; Lai W; Hu C; Dai Y; Li G; Zhang R; Zhao Y
Neoplasia; 2024 Feb; 48():100966. PubMed ID: 38237304
[TBL] [Abstract][Full Text] [Related]
10. Deciphering the immune reaction leading to spontaneous melanoma regression: initial role of MHCII
Blanc F; Bertho N; Piton G; Leplat JJ; Egidy G; Bourneuf E; Vincent-Naulleau S; Prévost-Blondel A
Cancer Immunol Immunother; 2023 Nov; 72(11):3507-3521. PubMed ID: 37526660
[TBL] [Abstract][Full Text] [Related]
11. Optimized collaboration of the first and third signals endows robust activity to T cells within the immunocompetent tumor microenvironment.
Wei J; Lin X; Han W
Cell Mol Immunol; 2023 Nov; 20(11):1393-1394. PubMed ID: 37308558
[No Abstract] [Full Text] [Related]
12. The role of αβ T-cells in spontaneous regression of melanoma tumors in swine.
Cizkova J; Sinkorova Z; Strnadova K; Cervinkova M; Horak V; Sinkora J; Stepanova K; Sinkora M
Dev Comp Immunol; 2019 Mar; 92():60-68. PubMed ID: 30308209
[TBL] [Abstract][Full Text] [Related]
13. A novel risk model based on anoikis: Predicting prognosis and immune infiltration in cutaneous melanoma.
Zhou Y; Wang C; Chen Y; Zhang W; Fu Z; Li J; Zheng J; Xie M
Front Pharmacol; 2022; 13():1090857. PubMed ID: 36726781
[TBL] [Abstract][Full Text] [Related]
14. Chemical carcinogen safety testing: OECD expert group international consensus on the development of an integrated approach for the testing and assessment of chemical non-genotoxic carcinogens.
Jacobs MN; Colacci A; Corvi R; Vaccari M; Aguila MC; Corvaro M; Delrue N; Desaulniers D; Ertych N; Jacobs A; Luijten M; Madia F; Nishikawa A; Ogawa K; Ohmori K; Paparella M; Sharma AK; Vasseur P
Arch Toxicol; 2020 Aug; 94(8):2899-2923. PubMed ID: 32594184
[TBL] [Abstract][Full Text] [Related]
15. Malignant Melanoma: Autoimmunity and Supracellular Messaging as New Therapeutic Approaches.
Motofei IG
Curr Treat Options Oncol; 2019 May; 20(6):45. PubMed ID: 31056729
[TBL] [Abstract][Full Text] [Related]
16. The role of tumour microenvironment: a new vision for cholangiocarcinoma.
Chen Z; Guo P; Xie X; Yu H; Wang Y; Chen G
J Cell Mol Med; 2019 Jan; 23(1):59-69. PubMed ID: 30394682
[TBL] [Abstract][Full Text] [Related]
17. TCR repertoire profiling of tumors, adjacent normal tissues, and peripheral blood predicts survival in nasopharyngeal carcinoma.
Jin YB; Luo W; Zhang GY; Lin KR; Cui JH; Chen XP; Pan YM; Mao XF; Tang J; Wang YJ
Cancer Immunol Immunother; 2018 Nov; 67(11):1719-1730. PubMed ID: 30155576
[TBL] [Abstract][Full Text] [Related]
18. A long-term survivor with esophageal melanoma and pulmonary metastasis after single-stage esophagectomy and lobectomy: Case report and literature review.
Zhao T; Kong FW; Wang H; Liu D; Wang CY; Luo JH; Zhang M; Wu WB
Medicine (Baltimore); 2017 May; 96(21):e7003. PubMed ID: 28538413
[TBL] [Abstract][Full Text] [Related]
19. The microenvironment in primary cutaneous melanoma with associated spontaneous tumor regression: evaluation for T-regulatory cells and the presence of an immunosuppressive microenvironment.
Gray A; Grushchak S; Mudaliar K; Kliethermes S; Carey K; Hutchens KA
Melanoma Res; 2017 Apr; 27(2):104-109. PubMed ID: 28125447
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
